Non-life insurers stare at steep loss ratios as non-Covid claims bite

While these monsoon-related ailments spike every year, this year the claims have been higher

health insurance
Non-life insurers have shelled out upwards of Rs 20,000 crore in Covid-related health claims since the onset of the pandemic
Subrata Panda Mumbai
3 min read Last Updated : Nov 26 2021 | 6:10 AM IST

Don't want to miss the best from Business Standard?

While Covid-related claims have tapered off following the devastating second wave, non-Covid claims — especially those arising out of infectious diseases — have spiked, adding to the burden of non-life insurers, who have seen their loss ratios in the health segment suffer in the past 18-20 months owing to mounting bills. 

Claims from dengue, malaria, and chikungunya have been particularly high this year. While these monsoon-related ailments spike every year, this year the claims have been higher. Experts say such claims will come down as winter sets in but it will be a bad year for insurers as far as the health segment is concerned and loss ratios will definitely go for a toss. 

“Last year, claims due to infectious diseases were very low, given people were mostly indoors due to Covid-19. This year, as Covid-19 has receded, people are resuming their normal lives, infectious diseases have risen and so have the claims. The year before Covid hit, claims from infectious disease were normal. From the claims perspective, it will be a difficult year for insurers and loss ratios will get impacted,” said Sanjay Datta, chief, underwriting & claims, ICICI Lombard General Insurance.

Speaking on similar lines, Bhaskar Nerurkar, head – health claims, Bajaj Allianz General Insurance, said, “At Bajaj Allianz General Insurance, non-Covid claims have gone up by 68 per cent year-on-year because last year there was a lockdown and this year things are a bit open. We are seeing a good number of dengue claims from some parts of the country such as Pune, Mumbai, Ahmedabad, and New Delhi. Other ailments such as gastroenteritis, enteric fever (typhoid) and viral pneumonia are also on the rise.”

“Such trends will certainly impact the loss ratios of the industry. Our loss ratios are a bit higher than what we had anticipated in the first six months of the fiscal year,” he added.


According to data released by Niva Bupa Health Insurance, claims for infectious diseases have seen a rise of about 500 per cent during the period of April-September, followed by claims related to the digestive system with a rise of 123 per cent. Overall, there has been a 33 per cent rise in health insurance claims between April and September over the last year.

Non-life insurers have shelled out upwards of Rs 20,000 crore in Covid-related health claims since the onset of the pandemic. These claims were unanticipated as they were not factored in while designing the product. Last year, they got some respite as non-Covid claims were muted, but this year the claims scenario for health insurers has been particularly bad because of the second wave and now the spike in non-Covid claims.

Amit Chhabra, chief, health business, Policybazaar.com, said, “Spike in claims from infectious diseases is still continuing. There is rampant increase in dengue cases, especially in the northern parts of the country. This has always been the trend but this year it has been particularly high.”

Another worrying trend is that the claim size of non-Covid claims have been rising and if this continues, it may warrant a revision in health insurance premiums sooner than later.

During an interview to Business Standard, Bhargav Dasgupta, MD & CEO, ICICI Lombard, had said the elective surgery spike could be temporary, but the average claim size spike is structural. “If I compare the present cost to what it was two years ago, there is a 20 per cent increase. If this sustains, it will have some repercussions on insurance premiums,” he had said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusNon-life insurersLife Insurance

Next Story